🇨🇦 R3-Total targeted treatment with azithromycin in Canada

R3-Total targeted treatment with azithromycin (R3-Total targeted treatment with azithromycin) regulatory status in Canada.

Marketing authorisation

R3-Total targeted treatment with azithromycin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is R3-Total targeted treatment with azithromycin approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for R3-Total targeted treatment with azithromycin in Canada?

Lihir Medical Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.